Premium
Continuous vancomycin in a pediatric cystic fibrosis patient
Author(s) -
McKinzie Cameron J.,
Esther Charles R.,
Vece Timothy J.
Publication year - 2018
Publication title -
pediatric pulmonology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.866
H-Index - 106
eISSN - 1099-0496
pISSN - 8755-6863
DOI - 10.1002/ppul.23844
Subject(s) - medicine , cystic fibrosis , vancomycin , intensive care medicine , pediatrics , staphylococcus aureus , bacteria , genetics , biology
Continuous vancomycin has been previously reported to maximize antimicrobial activity while avoiding toxicities associated with dose escalation, but the efficacy of this dosing strategy has not been reported. This case report describes the successful use of continuous vancomycin, including improvement in lung function and avoidance of nephrotoxicity, demonstrated in a pediatric cystic fibrosis (CF) patient with MRSA.